Benjamin A H Smith

9PUBLICATIONS
37CO-AUTHORS
Cellular nervous systemMolecular targetsGlycoconjugatesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 30, 2023
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease.

Ellen R Bowen, Phillip DiGiacomo, Hannah P Fraser

|Mar 10, 2023
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.

Benjamin A H Smith, Anja Deutzmann, Kristina M Correa

|Jan 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

Johanna Theruvath, Marie Menard, Benjamin A H Smith

|Feb 09, 2021
Author Correction: The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.

Benjamin A H Smith, Carolyn R Bertozzi

|Jan 26, 2021
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.

Simon Wisnovsky, Leonhard Möckl, Stacy A Malaker

Pageof 2